1 May 2025
📄FDA Notice on Financial Disclosure for Clinical Investigators
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Financial Disclosure by Clinical Investigators
Summary
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Agencies
- Health and Human Services Department
- Food and Drug Administration
Business Impact
$$ - Med
This notice outlines compliance requirements for financial disclosure by clinical investigators involved in FDA-regulated studies, impacting pharmaceutical and medical device companies. Sponsors must compile and submit disclosures, potentially influencing operational costs and regulatory best practices.